Table 2:

Statements and progress over the 3 Delphi rounds toward consensus on out-of-hospital transfusion protocols

Domain; statementMedian score* (range) (abstaining vote if applicable)Round 3
Round 1Round 2
1. General oversight and clinical governance
1.17 (5–7)
Accept revised version
1.27 (2–7)
Accept revised version
1.37 (3–7; 1)
Accept revised version
1.47 (2–7)
Accept revised version
1.57 (2–7)
Round 2 (critical commentary)
7 (5–7)
Accept as written
1.67 (2–7)
Accept revised version
1.76 (2–7; 1)
Accept revised version
1.86 (2–7; 2)
Round 2 (critical commentary)
7 (4–7)
Round 2 (critical commentary)
Consensus achieved
Accept revised version
1.97 (5–7)
Round 2 (critical commentary)
6 (4–7)
Round 2 (critical commentary)
Consensus achieved
Accept revised version
1.107 (3–7)
Round 2 (critical commentary)
7 (5–7)
Accept as written
1.116 (2–7)
Round 2 (critical commentary)
7 (5–7; 1)
Round 2 (critical commentary)
Consensus achieved
Accept revised version
1.12New statement6 (1–7)
Accept revised version
1.13New statement7 (4–7)
Accept revised version
1.147 (2–7)
Merged with other statement
2. Storage and transport of blood components and products
2.17 (1–7; 2)
Accept revised version
2.27 (2–7)
Accept revised version
2.3New statement6 (1–7)
Round 2 (critical commentary)
Consensus achieved
Accept revised version
2.4New statement7 (4–7)
Accept as written
3. Initiation of out-of-hospital transfusion
3.16 (3–6; 1)
Round 2 (critical commentary)
6 (1–7)
Round 2 (critical commentary)
Consensus achieved
Accept revised version
3.26 (2–7; 1)
Accept revised version
3.36 (1–7; 1)
Round 2 (critical commentary)
6 (3–7; 1)
Round 2 (critical commentary)
Consensus achieved
Accept revised version
3.47 (6–7)
Accept as written
3.54 (1–7)
Round 2 (score)
5 (2–7)
Round 2 (score)
Consensus achieved
Accept revised version
3.67 (1–7; 1)
Merged with other statement
3.76 (1–7)
Round 2 (critical commentary)
6 (4–7)
Merged with other statement
3.84 (1–7; 2)
Round 2 (score)
4 (1–7)
Merged with other statement
4. Types of blood components and products
4.16 (1–7) Accept revised version
4.26 (1–7; 3)
Round 2 (critical commentary)
6 (3–7)
Accept revised version
4.35 (1–7; 1)
Round 2 (score)
5 (1–7)
Round 2 (score)
Consensus achieved
Accept revised version
4.4New statement6 (5–7)
Accept as written
4.55 (1–7; 1)
Round 2 (score)
5 (1–7)
Round 2 (score)
Consensus achieved
Accept as written
4.65 (1–7)
Round 2 (score)
5 (1–7)
Round 2 (score)
No consensus
4.76 (2–7)
Merged with other statement
4.86 (1–7)
Merged with other statement
5. Delivery and monitoring of out-of-hospital transfusion
5.17 (5–7)
Round 2 (critical commentary)
7 (5–7)
Accept as written
5.27 (1–7; 1)
Accept revised version
5.37 (1–7)
Accept revised version
5.47 (5–7)
Accept as written
5.56 (1–7; 1)
Accept revised version
5.6New statement7 (4–7)
Accept as written
5.77 (2–7)
Merged with other statement
6. Indications for and use of transfusion adjuncts
6.17 (5–7)
Accept revised version
6.27 (5–7)
Accept revised version
6.36 (4–7)
Accept revised version
6.47 (5–7; 1)
Accept revised version
7. Resuscitation targets to guide transfusion
7.16 (4–7)
Accept revised version
7.26 (4–7)
Accept revised version
7.3New statement5 (2–7; 1)
Round 2 (score)
No consensus
  • * On a Likert scale ranging from 1 (“Definitely should not include”) to 7 (“Definitely should include”).

  • Panel discussion results.